News
LVTX
1.740
+7.23%
0.120
Weekly Report: what happened at LVTX last week (1117-1121)?
Weekly Report · 11/24/2025 09:01
LAVA Therapeutics Delists from Nasdaq and Changes Leadership
TipRanks · 11/21/2025 13:31
Weekly Report: what happened at LVTX last week (1110-1114)?
Weekly Report · 11/17/2025 09:01
LAVA Therapeutics to Delist from Nasdaq Amid Acquisition
TipRanks · 11/13/2025 14:03
LAVA intents to delist from Nasdaq
Seeking Alpha · 11/13/2025 13:51
Lava Therapeutics announces intent to delist from Nasdaq
TipRanks · 11/13/2025 12:45
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq
Barchart · 11/13/2025 06:30
Weekly Report: what happened at LVTX last week (1103-1107)?
Weekly Report · 11/10/2025 09:01
LAVA Therapeutics Approves Merger with New Topco B.V.
TipRanks · 11/07/2025 21:33
Weekly Report: what happened at LVTX last week (1027-1031)?
Weekly Report · 11/03/2025 09:01
Weekly Report: what happened at LVTX last week (1020-1024)?
Weekly Report · 10/27/2025 09:01
Major Stakeholder Sells Millions in LAVA Therapeutics Stock!
TipRanks · 10/21/2025 02:01
Shareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement
Barchart · 10/20/2025 11:58
Weekly Report: what happened at LVTX last week (1013-1017)?
Weekly Report · 10/20/2025 09:01
LAVA Therapeutics Amends Share Purchase Agreement
TipRanks · 10/17/2025 16:18
XOMA and LAVA Therapeutics Announce Amendment To Purchase Agreement; LAVA Shareholders Who Tender Their Shares Will Now Receive An Initial Cash Amount Per Share Of $1.04; Amendment To Agreement With LAVA Includes Updated CVR Terms For Tender Offer
Benzinga · 10/17/2025 15:48
Weekly Report: what happened at LVTX last week (1006-1010)?
Weekly Report · 10/13/2025 09:01
Major Shareholder Offloads LAVA Therapeutics Stock!
TipRanks · 10/11/2025 02:01
Weekly Report: what happened at LVTX last week (0929-1003)?
Weekly Report · 10/06/2025 09:01
LAVA Therapeutics Extends Tender Offer Deadline
Barchart · 10/03/2025 16:46
More
Webull provides a variety of real-time LVTX stock news. You can receive the latest news about LAVA Therapeutics N.V. through multiple platforms. This information may help you make smarter investment decisions.
About LVTX
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.